Discover the insights you need to make better decisions today, to shape the future with confidence.
See more
EY helps clients create long-term value for all stakeholders. Enabled by data and technology, our services and solutions provide trust through assurance and help clients transform, grow and operate.
Strategy and Transactions
How a cosmetics giant’s transformation strategy is unlocking value
13 Sep 2023Nobuko Kobayashi
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
See more
Press release
15 Sep 2026Gigi O’Brien
Press release
29 Jul 2026Michael Curtis
Recent Searches
Trending
Top 10 geopolitical developments for 2024
An even more complex geopolitical environment is on the horizon. Learn how businesses need to innovate and adapt their strategies to stay ahead.
12 Dec 2023 Geostrategy
Four factors to guide investment in battery storage
RECAI 63: Demand for battery energy storage is growing amid grid volatility. The EY ranking of investment hotspots highlights opportunities. Learn more.
14 Jun 2024
How supply chains benefit from using generative AI
Early use cases of generative AI in supply chains prove its worth in delivering cost savings and a simplified user experience. Read more.
09 Jan 2024 AIEY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead
Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.
As EY Global and EMEIA Life Sciences Sector Lead, Daniel is passionate about helping life sciences companies deliver better patient outcomes in the most efficient and effective way that can mutually benefit firms, payors, providers and patients.
Daniel started his career at a major pharmaceutical company and later in the NHS (National Health Service). Within pharma, Daniel managed the integration of the Welcome acquisition into Europe; implemented the UK pharmacy-agency distribution model, an industry first; managed a healthcare venture fund which sought to create physician-led companies; and then lead the sales and marketing for the European Neurology franchise. Within the NHS, Daniel created the first commercial clinical Site Management Organization that used the NHS’s unique data set to accelerate access to clinical trials.
Daniel earned a BSc (1st Hons) in Geography from the University of Bristol and an MSc in Computer and Information Science.
“Every day in the life sciences sector, I am able to see many opportunities to help build a better working world. Our challenge, however, is making sure that we focus our efforts on the transformational projects that will enable the greatest number of patients to gain access to the right treatments.”